Business Context and Reporting Period
This Form 8-K Current Report was filed by Global Medical REIT Inc. (GMRE) on October 3, 2019, regarding events occurring on September 30, 2019. The filing details a material amendment to the Company's credit facility and the execution of new interest rate swaps. Note: The request metadata references "Chiron Real Estate Inc.," but the filing text explicitly identifies the registrant as Global Medical REIT Inc.
Key Financial Metrics and Debt Structure
The filing focuses on debt restructuring rather than operating performance metrics such as revenue or profit, which are not provided in this document.
- Total Credit Facility Capacity: Increased to $500 million.
- Term Loan Component: Increased from $175 million to $300 million.
- Revolver Component: Reduced to $200 million capacity.
- Accordion Feature: A new $150 million accordion feature was added.
- Interest Rate Hedging: New swaps with a notional amount of $130 million were executed, fixing the weighted-average LIBOR component of the entire Term Loan balance at 2.17%.
Material Changes Versus Prior Period
The primary material change is the amendment to the Amended and Restated Credit Facility (A&R Credit Facility) with BMO Harris Bank N.A. and the addition of Wells Fargo Bank as a lender. Specific changes include:
- Debt Reallocation: $50 million was reallocated from the Revolver to the Term Loan.
- Covenant Adjustment: The 95% AFFO payout limitation under the restricted payments financial covenant was deferred from the fourth quarter of 2019 to the fourth quarter of 2020.
- Benchmark Rate: A mechanism was added to determine an alternative benchmark rate to LIBOR.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance on revenue or earnings. Management commentary is limited to the strategic rationale for the credit facility amendment, which includes increasing borrowing capacity and managing interest rate risk. The filing notes that borrowing availability is limited by a quarterly borrowing base valuation of certain properties owned by Subsidiary Guarantors. No specific risks or contingencies beyond standard debt covenants are detailed in this summary.
Key Facts for Investor Verification
- Verify the impact of the $130 million interest rate swaps on the Company's future interest expense and cash flow.
- Confirm the current utilization levels of the $200 million Revolver and the $300 million Term Loan.
- Review the deferred 95% AFFO payout limitation to understand future dividend distribution constraints.
- Examine the quarterly borrowing base valuation to assess actual available liquidity versus total facility capacity.